BRIP1 GENE MUTATION

Clinical trials for BRIP1 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new BRIP1 GENE MUTATION trials appear

Sign up with your email to follow new studies for BRIP1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 4 Terminated 1

Cancer drug niraparib tested before prostate surgery – early trial stopped

Disease control Terminated

This phase II trial tested the drug niraparib (Zejula) in 11 men with high-risk prostate cancer that had not spread. All men had specific DNA repair gene mutations. They took niraparib before having their prostate removed surgically. The goal was to see if the drug could eliminat…

Matched conditions: BRIP1 GENE MUTATION

Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC

BRIP1 GENE MUTATION

Get alerted when new BRIP1 GENE MUTATION trials appear

Cancer drug niraparib tested before prostate surgery – early trial stopped